PCM
CNMD icon

Palisade Capital Management’s CONMED CNMD Stock Holding History

Palisade Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,800
Closed -$273K – 372
2024
Q3 		$273K Hold
3,800
– – 0.01% 351
2024
Q2 		$263K Buy
3,800
+1,250
+49% +$91.2K 0.01% 348
2024
Q1 		$204K Buy
+2,550
New +$227K 0.01% 354

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Palisade Capital Management's CNMD Position: Q4 2024 in Review

Palisade Capital Management sold out of CONMED (CNMD) in Q4 2024, closing a stake of 3,800 shares — an estimated $273K sold.

Palisade Capital Management first reported a position in CNMD in Q1 2024 and held it in 3 quarters. The position peaked at $273K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Palisade Capital Management reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Palisade Capital Management sold 3,800 CONMED shares in Q4 2024, an estimated $273K.
  • Palisade Capital Management first reported a position in CONMED in Q1 2024 and held it in 3 quarters.
  • Palisade Capital Management's CONMED position peaked at $273K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Palisade Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.